Graphite Bio, Inc. (GRPH) NASDAQ
$3.18 (0.09) (-2.75%)
Market Cap: $185.19M
As of 03/21/24 04:00 PM EDT. Market closed.
Graphite Bio, Inc. (GRPH)
NASDAQ
$3.18
(0.09) (-2.75%)
Market Cap: $185.19M
As of 03/21/24 04:00 PM EDT. Market closed.
Add to Portfolio
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Kimberlee Cobleigh Drapkin CPA
Full Time Employees
6
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$5.49M
Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Kimberlee Cobleigh Drapkin CPA
Full Time Employees
6
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$5.49M
Address
201 Haskins Way, CA, South San Francisco, 94080.
PRICE CHART FOR GRAPHITE BIO, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.20
Previous Close
$3.27
Days Range
$3.05 - $3.23
52 week range
$3.05 - $29.82
Volume
299,406
Avg. Volume (30 days)
40,955
Market Cap
$185.19M
Dividend Yield
32.39%
P/E
(0.21)
Shares Outstanding
58,236,900
Open
$3.20
Previous Close
$3.27
Days Range
$3.05 - $3.23
52 week range
$3.05 - $29.82
Volume
299,406
Avg. Volume (30 days)
40,955
Market Cap
$185.19M
Dividend Yield
32.39%
P/E
(0.21)
Shares Outstanding
58,236,900
FINANCIAL STATEMENTS FOR GRAPHITE BIO, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GRAPHITE BIO, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Schimmelpennink Evert B. | President, CEO and Secretary | Jul 22, 2024 | Option Exercise | $1.04 | 45,000 | 46,800 | 45,000 | Jul 23, 2024, 08:16 PM |
| Chevallard Daniel R. | Chief Financial Officer | May 14, 2024 | Buy | $15.68 | 3,188 | 49,988 | 3,188 | May 15, 2024, 04:13 PM |
| MCCOLLUM JAMES W | Director | May 13, 2024 | Buy | $15.99 | 31,332 | 501,093 | 525,565 | May 14, 2024, 05:29 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 21, 2024 | Buy | $15.03 | 998,009 | 15,000,075 | 3,319,339 | Mar 25, 2024, 08:48 PM |
| MCCOLLUM JAMES W | Director | Mar 21, 2024 | Option Exercise | $15.03 | 16,633 | 249,992 | 494,233 | Mar 25, 2024, 08:42 PM |
| Samsara BioCapital, L.P. | 10% Owner | Apr 12, 2022 | Buy | $4.08 | 350,000 | 1,428,000 | 8,459,314 | Apr 13, 2022, 07:40 PM |
| Samsara BioCapital, L.P. | 10% Owner | Apr 11, 2022 | Buy | $4.07 | 74,464 | 303,068 | 8,109,314 | Apr 13, 2022, 07:40 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Apr 11, 2022 | Buy | $4.01 | 5,000 | 20,050 | 299,941 | Apr 13, 2022, 07:35 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 24, 2022 | Buy | $8.70 | 23,000 | 200,100 | 8,034,850 | Jan 25, 2022, 02:30 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 21, 2022 | Buy | $8.99 | 100,000 | 899,000 | 8,011,850 | Jan 25, 2022, 02:30 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 20, 2022 | Buy | $8.92 | 43,105 | 384,497 | 7,911,850 | Jan 21, 2022, 01:48 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 19, 2022 | Buy | $9.24 | 54,565 | 504,181 | 7,868,745 | Jan 21, 2022, 01:48 PM |
| Samsara BioCapital, L.P. | 10% Owner | Dec 15, 2021 | Buy | $10.19 | 22,329 | 227,533 | 7,814,180 | Dec 20, 2021, 01:46 PM |
| Samsara BioCapital, L.P. | 10% Owner | Nov 22, 2021 | Buy | $10.15 | 201,685 | 2,047,103 | 7,791,851 | Nov 24, 2021, 01:31 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 15, 2021 | Buy | $12.49 | 2,300 | 28,727 | 7,590,166 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 14, 2021 | Buy | $12.50 | 3,100 | 38,750 | 7,587,866 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 13, 2021 | Buy | $13.22 | 45,400 | 600,188 | 7,584,766 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 08, 2021 | Buy | $13.12 | 75,000 | 984,000 | 7,539,366 | Oct 08, 2021, 05:09 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 07, 2021 | Buy | $14.94 | 9,021 | 134,774 | 7,464,366 | Oct 08, 2021, 05:09 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 06, 2021 | Buy | $13.83 | 61,475 | 850,199 | 7,455,345 | Oct 08, 2021, 05:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM |
| Jerel Davis | Director | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM |
| Shah Smital | Director | Jun 29, 2021 | Buy | $17.00 | 5,882 | 99,994 | 5,882 | Jul 01, 2021, 07:00 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Apr 18, 2021 | Option Exercise | $6.11 | 3,383 | 20,670 | 285,345 | Jul 01, 2021, 07:00 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Jan 15, 2021 | Option Exercise | $0.30 | 91,406 | 27,422 | 281,962 | Jul 01, 2021, 07:00 PM |
| JIMENEZ JOSEPH | Director | Jan 14, 2021 | Option Exercise | $0.30 | 49,876 | 14,963 | 153,815 | Jul 01, 2021, 07:00 PM |
| Lehrer-Graiwer Joshua | PRESIDENT AND CEO | Jan 16, 2021 | Option Exercise | $0.30 | 374,013 | 112,204 | 1,153,544 | Jul 01, 2021, 07:00 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 500,000 | 8,500,000 | 7,393,870 | Jul 01, 2021, 05:39 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR GRAPHITE BIO, INC.
STOCK BUYBACKS FOR GRAPHITE BIO, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.97%
1Q
06/30/2023
1.88%
2Q
03/31/2023
3.49%
3Q
12/31/2022
3.76%
4Q
09/30/2022
4.72%
5Q
06/30/2022
5.94%
6Q
03/31/2022
7.05%
7Q
09/30/2021
9.56%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GRAPHITE BIO, INC.
LOADING...